Christoph Lahtz

927 total citations
11 papers, 619 citations indexed

About

Christoph Lahtz is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Christoph Lahtz has authored 11 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 4 papers in Immunology. Recurrent topics in Christoph Lahtz's work include Epigenetics and DNA Methylation (4 papers), Cancer Genomics and Diagnostics (3 papers) and Antenna Design and Analysis (2 papers). Christoph Lahtz is often cited by papers focused on Epigenetics and DNA Methylation (4 papers), Cancer Genomics and Diagnostics (3 papers) and Antenna Design and Analysis (2 papers). Christoph Lahtz collaborates with scholars based in United States, Germany and South Korea. Christoph Lahtz's co-authors include Gerd P. Pfeifer, Reinhard Dammann, Peter Helmbold, Hua Yu, Andreas Herrmann, Gregory Cherryholmes, Xin Hong, Claudia Kowolik, Marcin Kortylewski and Chunyan Zhang and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Cancer Research.

In The Last Decade

Christoph Lahtz

11 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christoph Lahtz United States 11 385 244 123 102 56 11 619
Katarzyna Urbańska United States 12 346 0.9× 388 1.6× 108 0.9× 127 1.2× 79 1.4× 16 671
Claudia S. Vetter‐Kauczok Germany 12 184 0.5× 196 0.8× 40 0.3× 161 1.6× 26 0.5× 18 488
Elena Benincasa Italy 7 245 0.6× 188 0.8× 71 0.6× 10 0.1× 43 0.8× 12 415
Jing‐biao Wu China 12 228 0.6× 153 0.6× 178 1.4× 108 1.1× 11 0.2× 17 494
Beatrice Casini Italy 11 180 0.5× 154 0.6× 183 1.5× 19 0.2× 13 0.2× 29 432
Lynn Meister United States 5 306 0.8× 128 0.5× 47 0.4× 41 0.4× 11 0.2× 8 436
Jiang-bo Tang United States 11 811 2.1× 294 1.2× 132 1.1× 211 2.1× 12 0.2× 12 1.1k
Peter Stiegler United States 12 586 1.5× 270 1.1× 71 0.6× 37 0.4× 5 0.1× 20 730
Talía Velasco-Hernández Spain 12 367 1.0× 358 1.5× 137 1.1× 125 1.2× 23 0.4× 20 692

Countries citing papers authored by Christoph Lahtz

Since Specialization
Citations

This map shows the geographic impact of Christoph Lahtz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Lahtz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Lahtz more than expected).

Fields of papers citing papers by Christoph Lahtz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Lahtz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Lahtz. The network helps show where Christoph Lahtz may publish in the future.

Co-authorship network of co-authors of Christoph Lahtz

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Lahtz. A scholar is included among the top collaborators of Christoph Lahtz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Lahtz. Christoph Lahtz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Aftabizadeh, Maryam, Yijia Li, Qianqian Zhao, et al.. (2021). Potent antitumor effects of cell-penetrating peptides targeting STAT3 axis. JCI Insight. 6(2). 15 indexed citations
2.
Herrmann, Andreas, Christoph Lahtz, Jieun Song, et al.. (2019). Integrin α6 signaling induces STAT3-TET3-mediated hydroxymethylation of genes critical for maintenance of glioma stem cells. Oncogene. 39(10). 2156–2169. 32 indexed citations
3.
Herrmann, Andreas, Toshikage Nagao, Chunyan Zhang, et al.. (2019). An effective cell-penetrating antibody delivery platform. JCI Insight. 4(14). 20 indexed citations
4.
Herrmann, Andreas, Christoph Lahtz, Toshikage Nagao, et al.. (2017). CTLA4 Promotes Tyk2-STAT3–Dependent B-cell Oncogenicity. Cancer Research. 77(18). 5118–5128. 38 indexed citations
5.
Herrmann, Andreas, Gregory Cherryholmes, Anne Schroeder, et al.. (2014). TLR9 Is Critical for Glioma Stem Cell Maintenance and Targeting. Cancer Research. 74(18). 5218–5228. 60 indexed citations
6.
Herrmann, Andreas, Saul J. Priceman, Maciej Kujawski, et al.. (2014). CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells. Journal of Clinical Investigation. 124(7). 2977–2987. 123 indexed citations
7.
Lahtz, Christoph, Steven Bates, Yong Jiang, et al.. (2012). Gamma Irradiation Does Not Induce Detectable Changes in DNA Methylation Directly following Exposure of Human Cells. PLoS ONE. 7(9). e44858–e44858. 31 indexed citations
8.
Lahtz, Christoph & Gerd P. Pfeifer. (2011). Epigenetic changes of DNA repair genes in cancer. Journal of Molecular Cell Biology. 3(1). 51–58. 146 indexed citations
9.
Helmbold, Peter, Christoph Lahtz, Alexander Enk, et al.. (2009). Frequent occurrence of RASSF1A promoter hypermethylation and merkel cell polyomavirus in merkel cell carcinoma. Molecular Carcinogenesis. 48(10). 903–909. 43 indexed citations
10.
Helmbold, Peter, Christoph Lahtz, Esther Herpel, Philipp A. Schnabel, & Reinhard Dammann. (2009). Frequent hypermethylation of RASSF1A tumour suppressor gene promoter and presence of Merkel cell polyomavirus in small cell lung cancer. European Journal of Cancer. 45(12). 2207–2211. 60 indexed citations
11.
Rastetter, Matthias, Undraga Schagdarsurengin, Christoph Lahtz, et al.. (2007). Frequent intra-tumoural heterogeneity of promoter hypermethylation in malignant melanoma.. PubMed. 22(9). 1005–15. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026